Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Bálint Alasztics"'
Autor:
Zita Pánczél, Zoltán Kukor, Dorina Supák, Bence Kovács, András Kecskeméti, Rita Czizel, Magdolna Djurecz, Bálint Alasztics, Krisztián Benedek Csomó, András Hrabák, Sándor Valent
Publikováno v:
BMC Pregnancy and Childbirth, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background Pravastatin, a known inducer of endothelial nitric-oxide synthase (eNOS) was demonstrated in human placenta, however the exact mechanism of it’s action is not fully understood. Since placental NO (nitric oxide) synthesis is of p
Externí odkaz:
https://doaj.org/article/c9af87c97fe14357aa9db4bda1eeb6ef
Autor:
Bálint, Alasztics, Árpád F, Kovács, Éva, Pállinger, Katalin É, Szabó-Taylor, Gábor, Szabó, Attila, Molvarec, Akos, Koller, János, Rigó
Publikováno v:
Pregnancy Hypertension. 31:54-59
An imbalanced redox homeostasis resulting in oxidative stress is present in preeclampsia. Peroxiredoxin-1 (PRDX1) and thioredoxin-1 (TRX1) regulatory enzymes are also contributing to the redox homeostasis, but were not investigated so far in preeclam
Autor:
Árpád Kovács, Nóra Fekete, Akos Koller, Edit I. Buzás, Attila Molvarec, Gábor Szabó, Bálint Alasztics, János Rigó, Éva Pállinger
Publikováno v:
Journal of Reproductive Immunology. 148:103380
It has previously been shown that preeclampsia is associated with disturbed hemostasis and that extracellular vesicles (EVs) play important role in the regulation of hemostatic homeostasis. Thus, we hypothesized that the altered procoagulant characte
Publikováno v:
Pregnancy Hypertension. 10:207-212
Introduction Hypertension is a common complication during pregnancy, affecting 10% of pregnant women worldwide. Several microRNA (miRNA) were shown to be involved in hypertensive disorders of pregnancy. In preeclampsia (PE), placental dysfunction cau
Introduction microRNAs (miRNAs) play important role in the regulation of placental development, and abnormal miRNA expression is associated with preeclampsia (PE). miRNAs are released from trophoblast cells to maternal blood flow, where they are high
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb1ba5da506b41693d5ac0f11edee9ce
Autor:
Edit I. Buzás, Bálint Alasztics, Árpád Kovács, Nóra Fekete, Lilla Turiák, János Rigó, László Kőhidai, Tamás Mészáros, Éva Pállinger, Orsolya Láng, András Ács
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-1 (2018)
A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.
Publikováno v:
Orvosi Hetilap. 155:1860-1866
Preeclampsia is one of the most common and most serious complications of pregnancy and the management of this condition still challenges obstetricians. Despite intensive research the etiology of preeclampsia still remains unclear. At the beginning of
Publikováno v:
Orvosi Hetilap. 153:1167-1176
Preeclampsia is a common and severe disease in pregnancy, a major cause of maternal and fetal morbidity and mortality. The main features of the disease are de novo hypertension after the 20th gestational week and proteinuria, and it is frequently acc
Publikováno v:
Pregnancy Hypertension. 13:S30
Introduction Placenta-specific miRNAs play important role in the regulation of pregnancy, and altered miRNA expression is associated with preeclampsia (PE). In PE, the placental dysfunction causes the abnormal release of extracellular miRNAs to the m
Publikováno v:
Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health. 9:46
Introduction Preeclampsia is the major cause of maternal and fetal morbidity and mortality, affecting 3–8% of pregnancies worldwide. Recent findings suggest that placenta-specific miRNAs may contribute to pregnancy-related diseases. The miR-517 fam